21 research outputs found
Prospective study of atopic status in infants of the cohort in Tokyo, Japan
Several risk factors for the development of allergic diseases are considered including, for example, the level of IgE in cord blood or in the peripheral blood of neonates and the antigenic effect of some foods that are ingested by both babies and mothers during pregnancy and during the lactation period. However, not all infants with atopic diathesis develop allergic diseases. To clarify the risk factors and the mechanism for developing allergic diseases, particularly bronchial asthma (BA), we prospectively investigated atopic diatheses and symptoms in children in a cohort using a questionnaire method. The factors correlated to development of allergic diseases, as a whole, at the age of 5â6 years were atopic family history and any allergic symptom at 4 months of age. However, not all subjects with atopic dermatitis developed BA later on. High levels of total IgE and positive IgE antibody against egg white were not risk factors for developing BA at the age of 5â6 years
Photosensitized Protein-Damaging Activity, Cytotoxicity, and Antitumor Effects of P(V)porphyrins Using Long-Wavelength Visible Light through Electron Transfer
Photodynamic
therapy (PDT) is a less-invasive treatment for cancer
through the administration of less-toxic porphyrins and visible-light
irradiation. Photosensitized damage of biomacromolecules through singlet
oxygen (<sup>1</sup>O<sub>2</sub>) generation induces cancer cell
death. However, a large quantity of porphyrin photosensitizer is required,
and the treatment effect is restricted under a hypoxic cellular condition.
Here we report the phototoxic activity of PÂ(V)Âporphyrins: dichloroPÂ(V)ÂtetrakisÂ(4-methoxyphenyl)Âporphyrin
(CLPÂ(V)ÂTMPP), dimethoxyPÂ(V)ÂtetrakisÂ(4-methoxyphenyl)Âporphyrin (MEPÂ(V)ÂTMPP),
and diethyleneglycoxyPÂ(V)ÂtetrakisÂ(4-methoxyphenyl)Âporphyrin (EGPÂ(V)ÂTMPP).
These PÂ(V)Âporphyrins damaged the tryptophan residue of human serum
albumin (HSA) under the irradiation of long-wavelength visible light
(>630 nm). This protein photodamage was barely inhibited by sodium
azide, a quencher of <sup>1</sup>O<sub>2</sub>. Fluorescence lifetimes
of PÂ(V)Âporphyrins with or without HSA and their redox potentials supported
the electron-transfer-mediated oxidation of protein. The photocytotoxicity
of these PÂ(V)Âporphyrins to HeLa cells was also demonstrated. CLPÂ(V)ÂTMPP
did not exhibit photocytotoxicity to HaCaT, a cultured human skin
cell, and MEPÂ(V)ÂTMPP and EGPÂ(V)ÂTMPP did; however, cellular DNA damage
was barely observed. In addition, a significant PDT effect of these
PÂ(V) porphyrins on a mouse tumor model comparable with the traditional
photosensitizer was also demonstrated. These findings suggest the
cancer selectivity of these PÂ(V)Âporphyrins and lower carcinogenic
risk to normal cells. Electron-transfer-mediated oxidation of biomacromolecules
by PÂ(V)Âporphyrins using long-wavelength visible light should be advantageous
for PDT of hypoxic tumor